Key result
Metabolic syndrome was present in 46.3% of patients with atrial fibrillation without structural heart disease, with no significant difference between persistent/permanent and paroxysmal AF (52.9% vs 44.6%, P=0.064).
Population
741 inpatients with atrial fibrillation in the absence of structural heart disease prior to catheter…
Design
Cross-sectional
Authors
Loading...
May warrant metabolic evaluation in AF ablation candidates; leaves open its role in remodeling or outcomes.
Observational (n=741)
No
Absolute Event Rate: 52.9% vs 44.6%
p-value: p=0.064
Metabolic syndrome is highly prevalent (46.3%) among Chinese patients with atrial fibrillation without structural heart disease undergoing catheter ablation, and its presence is associated with increased left atrial diameter.
Tang et al. (2009) conducted an observational in Atrial fibrillation without structural heart disease (n=741). Persistent/permanent AF vs. Paroxysmal AF was evaluated on Prevalence of metabolic syndrome (p=0.064). Metabolic syndrome was present in 46.3% of patients with atrial fibrillation without structural heart disease, with no significant difference between persistent/permanent and paroxysmal AF (52.9% vs 44.6%, P=0.064).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: